Eleven Biotherapeutics CEO Thomas Cannell receives $2M in 2018
Eleven Biotherapeutics reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Eleven Biotherapeutics reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, four executives at Eleven Biotherapeutics received on average a compensation package of $1.1M, a 109% increase compared to previous year.
Average pay of disclosed executives at Eleven Biotherapeutics
Thomas R. Cannell, Chief Executive Officer, received $2M in total. 71% of Cannell's compensation, or $1.4M, was in option awards. Cannell also received $98K in non-equity incentive plan, $198K in salary, as well as $280K in other compensation.
Stephen A. Hurly, Chief Executive Officer, received a compensation package of $1.2M, which increased by 12% compared to previous year. 57% of the compensation package, or $682K, was in other compensation.
Richard F. Fitzgerald, Chief Financial Officer, earned $665K in 2018, a 882% increase compared to previous year.
Dennis Kim, Chief Medical Officer, received $513K in 2018.
Related executives
You may also like
Source: SEC filing on April 30, 2019.